GM
65
-3
CSCO
63
2
TDC
75
4
T
50
3
MPC
47
3
VRSK
73
5
ROK
55
8
EOG
58
2
INTU
51
2
MCO
73
3
EQT
59
2
HAS
30
2
URI
53
-2
ORLY
53
-3
HSIC
54
-3
NAVI
41
-3
QRVO
6
2
HD
47
-5
DE
46
3
LH
42
2
GM
65
-3
CSCO
63
2
TDC
75
4
T
50
3
MPC
47
3
VRSK
73
5
ROK
55
8
EOG
58
2
INTU
51
2
MCO
73
3
EQT
59
2
HAS
30
2
URI
53
-2
ORLY
53
-3
HSIC
54
-3
NAVI
41
-3
QRVO
6
2
HD
47
-5
DE
46
3
LH
42
2
Financhill
Back

Viking Therapeutics Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

VKTX
Viking Therapeutics

Last Price:
53.70
Seasonality Move:
50.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Viking Therapeutics Stock Forecast

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 90.2% based on the past 9 years of stock performance.
  • Viking Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
  • Is Viking Therapeutics Stock Undervalued?
    The current Viking Therapeutics [VKTX] share price is $51.53. The Score for VKTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Viking Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 90.2% based on the past 9 years of stock performance.

Viking Therapeutics Stock Rating

Sell
37
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics overpriced?

  • Viking Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Viking Therapeutics Stock Price History

Is VKTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com

52-Week Data

52-Week High:
99.41
52-Week Low:
11.21

Prediction Charts

Market Cap:
5.74B
Price in USD:
51.53
Volume:
3.5M
Beta:
1.32

Technical Analysis

SMA50:
64.16
SMA100:
60.62
SMA200:
61.94
52-Wk Change:
337.81%

Stock Predictions

  • Is Viking Therapeutics stock public?
    Yes, Viking Therapeutics is a publicly traded company.
  • What is the Viking Therapeutics stock quote today?
    The Viking Therapeutics stock price is 51.53 USD today.
  • How to buy Viking Therapeutics stock online?
    You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 73.67 72.88 75.28 72.45
Nov-4 78.30 63.14 79.10 62.80
Nov-5 63.53 64.63 67.73 62.50
Nov-6 65.59 65.88 66.38 62.80
Nov-7 66.10 68.85 69.10 64.80
Nov-8 68.74 68.48 70.41 65.77
Nov-11 68.80 63.00 68.87 62.81
Nov-12 62.46 60.61 62.50 57.37
Nov-13 61.23 55.04 61.23 54.54
Nov-14 55.00 53.57 56.00 53.56
Nov-15 53.18 49.58 53.20 48.98
Nov-18 49.10 49.11 50.51 47.65
Nov-19 48.75 51.51 51.68 47.85
Nov-20 52.70 51.53 53.04 50.40

Viking Therapeutics Earnings

Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Viking Therapeutics Forecast Revenue Growth

Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.